The same bottle of insulin that costs $98 in Canada costs $450 in the United States. The same Humira prescription that runs $1,300 per month in the U.S. costs $200 in Germany. The same Lipitor that Americans pay $165 for can be purchased in the UK for $6. These are not anomalies — they are the predictable result of a drug pricing system that is uniquely, deliberately, and profoundly broken in America.
According to a RAND Corporation analysis, Americans pay 2.56 times more on average for brand-name prescription drugs than residents of 32 other high-income countries. For some drugs, the gap is far larger. And unlike virtually every other developed nation, the United States has historically had no mechanism for the federal government to negotiate drug prices — leaving pharmaceutical companies free to charge whatever the market will bear.
Why American Drug Prices Are So High
The reasons for America's drug pricing exceptionalism are structural and deeply embedded in the political economy of the pharmaceutical industry.
No government price negotiation (until recently). Medicare, the largest drug purchaser in the country, was legally prohibited from negotiating drug prices until the Inflation Reduction Act of 2022 gave it limited authority to do so for a small number of drugs. Every other developed nation's government negotiates prices directly with pharmaceutical companies, creating a ceiling on what can be charged.
Patent protection and market exclusivity. Drug companies receive 20-year patents on new drugs, and can extend effective market exclusivity through a variety of legal strategies — including minor reformulations that reset the patent clock. This prevents generic competition for far longer than the original patent system intended.
Pharmacy Benefit Manager opacity. The drug supply chain in the U.S. runs through Pharmacy Benefit Managers (PBMs) — middlemen who negotiate rebates from drug companies on behalf of insurers. These rebates are often not passed through to consumers, and the entire system operates with minimal transparency.
📊 The Numbers
Americans spend approximately $600 billion per year on prescription drugs — about $1,800 per person. Roughly 1 in 4 Americans report difficulty affording their medications. An estimated 3.9 million Americans travel abroad each year to purchase prescription drugs at lower prices.
What's Actually Changing
Several significant policy developments in 2025 have the potential to reduce drug prices for American consumers, though the impact remains uncertain.
Medicare Drug Price Negotiation. Under the Inflation Reduction Act, Medicare negotiated prices for 10 high-cost drugs that took effect in January 2026. The negotiated prices represent reductions of 38–79% from list prices for drugs including Eliquis, Jardiance, Xarelto, Januvia, and others. While this affects only Medicare beneficiaries and only a small number of drugs initially, it establishes an important precedent.
Most-Favored-Nation Executive Order. In May 2025, President Trump signed an executive order directing federal agencies to work toward ensuring that Americans pay no more for prescription drugs than the lowest price paid by any other developed nation. The implementation details remain unclear, and pharmaceutical companies have challenged the order, but it signals political pressure for price reduction.
Drug Price Transparency Act. Legislation introduced in 2025 would require pharmaceutical companies to disclose the actual cost of developing and manufacturing drugs, as well as the prices charged in other countries. Greater transparency is a prerequisite for meaningful reform.
What You Can Do Right Now to Lower Your Drug Costs
Ask for generics. Generic drugs contain the same active ingredients as brand-name drugs and are required by law to be bioequivalent. They typically cost 80–85% less. Always ask your doctor if a generic is available.
Use GoodRx and similar tools. GoodRx, RxSaver, and similar platforms aggregate discount coupons from pharmacy benefit managers. For many common drugs, these coupons can reduce costs by 50–80% — sometimes making the drug cheaper than your insurance copay.
Apply for manufacturer patient assistance programs. Most major pharmaceutical companies have patient assistance programs that provide free or heavily discounted drugs to patients who meet income requirements. NeedyMeds.org maintains a comprehensive database of these programs.
Consider Mark Cuban's Cost Plus Drugs. Cost Plus Drugs (costplusdrugs.com) sells generic drugs at manufacturing cost plus a 15% markup and a $3 pharmacy fee. For many common generics, this results in prices 80–90% below retail pharmacy prices.
✅ Check If You Qualify for Medicare Savings
If you're on Medicare, the Extra Help program (also called the Low Income Subsidy) can dramatically reduce your prescription drug costs. In 2026, beneficiaries who qualify pay no more than $11.20 for brand-name drugs and $4.50 for generics. Contact your local Social Security office or call 1-800-MEDICARE to check eligibility.